Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: Lessons learned and challenges remaining

Journal of the National Cancer Institute

Volumn 93, Issue 1, 2001, Pages 4-5

  Fisher, Richard I ^a,b,c  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b Southwest Oncology Group   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; PREDNISONE; VINCRISTINE;

ADVANCED CANCER; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; EDITORIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0035798793     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.1.4     Document Type: Editorial

References (10)

1. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
2. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
3. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: Value of augmented preparative regimens-a Southwest oncology group trial
4. Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: Randomized phase III EORTC study
5. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma in first complete remission: A study of 464 patients
6. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: Results of a prospective randomized trial by the non-Hodgkin's lymphoma cooperative study group
7. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma
8. Failure of first-line inductive high-dose chemotherapy (HDC) in poor-risk patients with aggressive lymphomas: Updated results of the randomized LNH93-3 study
9. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma
10. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 protocol-a groupe d'Etude des lymphomes de l'Adulte study